» Articles » PMID: 30680566

Short- Versus Long-course Therapy in Gram-negative Bacilli Bloodstream Infections

Overview
Publisher Springer
Date 2019 Jan 26
PMID 30680566
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteremia due to gram-negative bacilli (GNB) is one of the most frequent causes of admission and prolongation of hospital stay. Nevertheless, optimal duration of antibiotic treatment is not clearly established. We designed an observational, prospective study of a cohort of adult patients with uncomplicated GNB bacteremia. They were classified according to the duration of treatment in short (7-10 days) or long (> 10 days) course. Mortality and bacteremia recurrence rate were evaluated, and propensity score for receiving short-course treatment was calculated. A total of 395 patients met eligibility criteria including 232 and 163 who received long- and short-course therapy, respectively. Median age was 71 years, 215 (54.4% male) and 51% had a urinary source. Thirty-day mortality was 12%. In multivariate analysis by logistic regression stratified according to propensity score quartile for receiving short-course therapy showed no association of duration of treatment with 30-day mortality or 90-day recurrence rate. Based on the results observed in our cohort, short-course therapy could be as safe and effective as longer courses.

Citing Articles

Clinical characteristics and bloodstream infection pathogens by gram-negative bacteria in different aged adults: A retrospective study.

Su L, Cao Y, Liu Y, Zhang J, Zhang G Medicine (Baltimore). 2024; 103(45):e40411.

PMID: 39533568 PMC: 11557057. DOI: 10.1097/MD.0000000000040411.


Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review.

Corona A, De Santis V, Agarossi A, Prete A, Cattaneo D, Tomasini G Antibiotics (Basel). 2023; 12(8).

PMID: 37627683 PMC: 10451333. DOI: 10.3390/antibiotics12081262.


Antibiotic stewardship in the ICU: time to shift into overdrive.

Mokrani D, Chommeloux J, De Chambrun M, Hekimian G, Luyt C Ann Intensive Care. 2023; 13(1):39.

PMID: 37148398 PMC: 10163585. DOI: 10.1186/s13613-023-01134-9.


Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis.

Turjeman A, von Dach E, Molina J, Franceschini E, Koppel F, Yelin D EClinicalMedicine. 2022; 55:101750.

PMID: 36483269 PMC: 9722443. DOI: 10.1016/j.eclinm.2022.101750.


Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.

Babich T, Naucler P, Valik J, Giske C, Benito N, Cardona R Infect Dis Ther. 2022; 11(4):1505-1519.

PMID: 35612693 PMC: 9334465. DOI: 10.1007/s40121-022-00657-1.


References
1.
Menashe G, Borer A, Yagupsky P, Peled N, Gilad J, Fraser D . Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Scand J Infect Dis. 2001; 33(3):188-93. DOI: 10.1080/00365540151060806. View

2.
Friedman N, Kaye K, Stout J, McGarry S, Trivette S, Briggs J . Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002; 137(10):791-7. DOI: 10.7326/0003-4819-137-10-200211190-00007. View

3.
Corona A, Bertolini G, Ricotta A, Wilson A, Singer M, Wilson A . Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J Antimicrob Chemother. 2003; 52(5):849-52. DOI: 10.1093/jac/dkg447. View

4.
Suljagic V, Cobeljic M, Jankovic S, Mirovic V, Markovic-Denic L, Romic P . Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control. 2005; 33(6):333-40. DOI: 10.1016/j.ajic.2005.03.010. View

5.
Horan T, Andrus M, Dudeck M . CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008; 36(5):309-32. DOI: 10.1016/j.ajic.2008.03.002. View